Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
59.46
+0.49 (0.83%)
After Hours: 59.55 +0.09 (0.15%)
May 27, 7:43PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 58.87 - 59.78
52 week 52.49 - 63.62
Open 59.09
Vol / Avg. 9.73M/10.64M
Mkt cap 166.10B
P/E 15.43
Div/yield 0.45/3.03
EPS 3.85
Shares 2.83B
Beta 0.34
Inst. own 75%
Jul 28, 2015
Q2 2015 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
Jul 28, 2015
Q2 2015 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
May 26, 2015
Merck & Co Inc Annual Shareholders Meeting
May 19, 2015
Merck & Co Inc at UBS Global Healthcare Conference - Webcast
May 13, 2015
Merck & Co Inc at Bank of America Merrill Lynch Health Care Conference - Webcast
Apr 28, 2015
Q1 2015 Merck & Co Inc Earnings Release
Apr 28, 2015
Q1 2015 Merck & Co Inc Earnings Call - Webcast
Mar 11, 2015
Merck & Co Inc at Barclays Healthcare Conference - Webcast
Mar 3, 2015
Merck & Co Inc at Cowen Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 10.16% 28.25%
Operating margin 15.24% 13.42%
EBITD margin - 53.26%
Return on average assets 3.72% 11.70%
Return on average equity 7.93% 24.22%
Employees 70,000 -
CDP Score - 88 B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc., is a health care company. The Company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments. The Pharmaceutical segment includes human health pharmaceutical and vaccine products consisting of therapeutic and preventive agents, sold by prescription, for treatment of human disorders. The Company has animal health operations that discover, develop, manufacture and market animal health products. The Consumer Care develops, manufactures and markets over-the-counter, foot care and sun care products.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Clark Golestani Executive Vice President, Chief Information Officer
Age: 48
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, Chief Ethics and Compliance Officer, General Counsel
Age: 52
Bio & Compensation  - Reuters
Bruce N. Kuhlik Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Willie A. Deese Executive Vice President, President - Merck Manufacturing Division
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 52
Bio & Compensation  - Reuters
Julie Louise Gerberding Executive Vice President - Strategic Communications, Global Public Policy & Population Health
Age: 59
Bio & Compensation  - Reuters
Roger M. Perlmutter M.D., Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 63
Bio & Compensation  - Reuters